IKZF1缺失的B细胞急性淋巴细胞白血病基因表达特征揭示MUC4的独特调控
该研究对比24例IKZF1缺失与32例IKZF1野生型B-ALL患者的基因表达特征,RNA测序发现黏附相关基因MUC4、SPP1、LAMB3、CLSTN2和MERTK失调,MUC4上调经另一B-ALL队列验证;染色质免疫沉淀显示IKZF1直接结合MUC4启动子和增强子序列;TARGET-ALL-P2数据库分析显示MUC4高表达与生存期缩短相关,作者提出MUC4表达可作为B-ALL中与IKZF1缺失相关的预后指标。
要点
- IKZF1缺失B-ALL患者中MUC4、SPP1、LAMB3、CLSTN2和MERTK等黏附相关基因表达失调。
- IKZF1可直接结合MUC4启动子和增强子序列,IKZF1缺失导致MUC4去抑制而上调。
- TARGET-ALL-P2数据库显示B-ALL中MUC4高表达与生存期缩短相关。
核心结论
- 作者提出MUC4表达可作为B-ALL中与IKZF1缺失相关的患者预后指标。
研究设计与样本
- 研究分析24例IKZF1缺失B-ALL患者与32例IKZF1野生型B-ALL患者的基因表达特征,采用RNA测序,并用另一B-ALL患者队列验证MUC4上调,通过染色质免疫沉淀检测IKZF1与MUC4调控序列的结合,并利用TARGET-ALL-P2数据库分析MUC4表达与生存的关系。
主要发现
- RNA测序显示IKZF1缺失B-ALL患者中MUC4、分泌型磷蛋白1(SPP1)、LAMB3、CLSTN2和MERTK等黏附相关基因失调。
- MUC4表达上调在另一B-ALL患者队列中得到验证。
- 染色质免疫沉淀观察到IKZF1直接结合MUC4启动子和增强子序列,提示IKZF1缺失后MUC4表达增加源于IKZF1对MUC4位点抑制的丧失。
- 利用TARGET-ALL-P2数据库观察到B-ALL患者中MUC4高表达与生存期缩短相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The IKAROS (IKZF1) transcription factor regulates the differentiation of pre-B cells to mature B lymphocytes. The loss of IKZF1 expression has been linked with increased matrix adhesion along with increased expression of stemness markers that form a hallmark of B-lymphoblasts. However, the spectrum of differentially regulated genes has not been investigated in detail in B-cell acute lymphoblastic leukaemia (B-ALL) patients expressing IKZF1 deletion. In this study, we analysed the gene expression signature of 24 B-ALL patients with IKZF1 deletion against 32 B-ALL patients with wild-type IKZF1. RNA sequencing revealed an adhesion signature corresponding to deregulation of MUC4, secreted phosphoprotein 1 (SPP1), LAMB3, CLSTN2 and MERTK. The upregulation of MUC4 expression was further validated in a B-ALL patient cohort. Moreover, by chromatin immunoprecipitation, we observed the direct binding of IKZF1 on MUC4 promoter and enhancer sequences. Thus, the increase in MUC4 expression upon IKZF1 deletion could be explained by a loss of IKZF1 repression on the MUC4 locus. Finally, using the TARGET-ALL-P2 database, we observed a correlation between decreased survival and high MUC4 expression in B-ALL patients. Thus, we propose MUC4 expression as an indicator of patient prognosis that correlates with the loss of IKZF1 in B-ALL.
引用
- Sharma P, Leons GK, Singh V, et al. Gene expression signature of IKZF1 deleted B-cell acute lymphoblastic leukaemia reveals a unique regulation of MUC4. Br J Haematol. 2025. PMID: 40878232. doi:10.1111/bjh.70014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。